These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Management of mTOR inhibitor side effects.
    Author: Creel PA.
    Journal: Clin J Oncol Nurs; 2009 Dec; 13 Suppl():19-23. PubMed ID: 19948456.
    Abstract:
    Although surgery remains the primary curative treatment for renal cell carcinoma (RCC), systemic therapy also is indicated in the advanced disease setting. This article reviews the role of mammalian target of rapamycin inhibitors in the treatment of metastatic RCC. A case study is presented to illustrate side-effect management issues commonly encountered by oncology nurses in clinical practice.
    [Abstract] [Full Text] [Related] [New Search]